TG Therapeutics, Inc. (TGTX) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 11 recommend buying, 1 recommend holding, and 1 recommend selling.
The analyst consensus price target for TGTX is $39.00, representing a +12.8% upside from the current price of $34.56. Price targets range from a low of $39.00 to a high of $39.00.
